nodes	percent_of_prediction	percent_of_DWPC	metapath
Oxymetazoline—NISCH—Paclitaxel—Docetaxel—skin cancer	0.0964	1	CbGdCrCtD
Oxymetazoline—NISCH—hair follicle—skin cancer	0.0588	0.0827	CbGeAlD
Oxymetazoline—NISCH—nipple—skin cancer	0.0399	0.0561	CbGeAlD
Oxymetazoline—HTR2A—hindlimb—skin cancer	0.0358	0.0503	CbGeAlD
Oxymetazoline—HTR1B—blood vessel—skin cancer	0.0355	0.05	CbGeAlD
Oxymetazoline—HTR1D—blood vessel—skin cancer	0.0344	0.0484	CbGeAlD
Oxymetazoline—HTR2A—appendage—skin cancer	0.0307	0.0432	CbGeAlD
Oxymetazoline—NISCH—mammalian vulva—skin cancer	0.0233	0.0328	CbGeAlD
Oxymetazoline—HTR1E—head—skin cancer	0.0227	0.0319	CbGeAlD
Oxymetazoline—ADRA1D—epithelium—skin cancer	0.0224	0.0315	CbGeAlD
Oxymetazoline—HTR2A—nerve—skin cancer	0.0218	0.0306	CbGeAlD
Oxymetazoline—HTR2A—endothelium—skin cancer	0.0185	0.0261	CbGeAlD
Oxymetazoline—ADRA2C—nipple—skin cancer	0.0182	0.0256	CbGeAlD
Oxymetazoline—HTR1D—connective tissue—skin cancer	0.0176	0.0248	CbGeAlD
Oxymetazoline—HTR2A—blood vessel—skin cancer	0.0171	0.024	CbGeAlD
Oxymetazoline—ADRA1D—female reproductive system—skin cancer	0.0166	0.0234	CbGeAlD
Oxymetazoline—HTR2B—skin of body—skin cancer	0.0148	0.0208	CbGeAlD
Oxymetazoline—ADRA2A—nipple—skin cancer	0.0145	0.0204	CbGeAlD
Oxymetazoline—ADRA1B—head—skin cancer	0.0142	0.02	CbGeAlD
Oxymetazoline—ADRA1D—head—skin cancer	0.0139	0.0196	CbGeAlD
Oxymetazoline—ADRA1A—epithelium—skin cancer	0.0129	0.0181	CbGeAlD
Oxymetazoline—HTR1B—female reproductive system—skin cancer	0.0128	0.0181	CbGeAlD
Oxymetazoline—HTR1D—female reproductive system—skin cancer	0.0124	0.0175	CbGeAlD
Oxymetazoline—HTR2C—female reproductive system—skin cancer	0.0123	0.0173	CbGeAlD
Oxymetazoline—HTR2A—neck—skin cancer	0.0122	0.0172	CbGeAlD
Oxymetazoline—NISCH—lymph node—skin cancer	0.0117	0.0164	CbGeAlD
Oxymetazoline—HTR2B—female reproductive system—skin cancer	0.0116	0.0163	CbGeAlD
Oxymetazoline—HTR1B—head—skin cancer	0.0107	0.0151	CbGeAlD
Oxymetazoline—ADRA2C—mammalian vulva—skin cancer	0.0106	0.015	CbGeAlD
Oxymetazoline—HTR1D—head—skin cancer	0.0104	0.0146	CbGeAlD
Oxymetazoline—ADRA2A—connective tissue—skin cancer	0.0103	0.0145	CbGeAlD
Oxymetazoline—HTR2C—head—skin cancer	0.0103	0.0145	CbGeAlD
Oxymetazoline—ADRA1A—lymphoid tissue—skin cancer	0.00991	0.0139	CbGeAlD
Oxymetazoline—HTR2B—head—skin cancer	0.00967	0.0136	CbGeAlD
Oxymetazoline—HTR2A—connective tissue—skin cancer	0.00876	0.0123	CbGeAlD
Oxymetazoline—ADRA2A—mammalian vulva—skin cancer	0.00849	0.0119	CbGeAlD
Oxymetazoline—HTR2A—epithelium—skin cancer	0.00832	0.0117	CbGeAlD
Oxymetazoline—ADRA1A—head—skin cancer	0.00798	0.0112	CbGeAlD
Oxymetazoline—ADRA2C—head—skin cancer	0.00761	0.0107	CbGeAlD
Oxymetazoline—ADRA2A—female reproductive system—skin cancer	0.00727	0.0102	CbGeAlD
Oxymetazoline—HTR2B—lymph node—skin cancer	0.00677	0.00952	CbGeAlD
Oxymetazoline—HTR2A—female reproductive system—skin cancer	0.00618	0.00869	CbGeAlD
Oxymetazoline—ADRA2A—head—skin cancer	0.00607	0.00854	CbGeAlD
Oxymetazoline—ADRA2C—lymph node—skin cancer	0.00533	0.0075	CbGeAlD
Oxymetazoline—HTR2A—head—skin cancer	0.00516	0.00726	CbGeAlD
Oxymetazoline—ADRA2A—lymph node—skin cancer	0.00425	0.00598	CbGeAlD
Oxymetazoline—HTR1D—Signaling Pathways—RASA1—skin cancer	0.000201	0.00104	CbGpPWpGaD
Oxymetazoline—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—skin cancer	0.000201	0.00104	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling by GPCR—SHH—skin cancer	0.000201	0.00104	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling by GPCR—PTGER4—skin cancer	0.000199	0.00103	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—GLI1—skin cancer	0.000199	0.00103	CbGpPWpGaD
Oxymetazoline—HTR1B—Signaling Pathways—SHH—skin cancer	0.000198	0.00103	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling Pathways—SUFU—skin cancer	0.000197	0.00102	CbGpPWpGaD
Oxymetazoline—HTR1B—Signaling Pathways—RASA1—skin cancer	0.000197	0.00102	CbGpPWpGaD
Oxymetazoline—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—skin cancer	0.000196	0.00102	CbGpPWpGaD
Oxymetazoline—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—skin cancer	0.000192	0.000996	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—GLI2—skin cancer	0.000192	0.000994	CbGpPWpGaD
Oxymetazoline—HTR1D—Signaling Pathways—SMO—skin cancer	0.000192	0.000994	CbGpPWpGaD
Oxymetazoline—HTR1D—Signaling Pathways—PTCH1—skin cancer	0.000192	0.000994	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling Pathways—SUFU—skin cancer	0.000191	0.000992	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling by GPCR—PTCH1—skin cancer	0.00019	0.000987	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling by GPCR—SMO—skin cancer	0.00019	0.000987	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—SUFU—skin cancer	0.000188	0.000977	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—GLI2—skin cancer	0.000188	0.000973	CbGpPWpGaD
Oxymetazoline—HTR1B—Signaling Pathways—SMO—skin cancer	0.000188	0.000973	CbGpPWpGaD
Oxymetazoline—HTR1B—Signaling Pathways—PTCH1—skin cancer	0.000188	0.000973	CbGpPWpGaD
Oxymetazoline—HTR2A—SIDS Susceptibility Pathways—IL6—skin cancer	0.000187	0.00097	CbGpPWpGaD
Oxymetazoline—HTR1D—Signaling Pathways—PTGER4—skin cancer	0.000187	0.000968	CbGpPWpGaD
Oxymetazoline—HTR2B—Signaling Pathways—SHH—skin cancer	0.000186	0.000965	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling by GPCR—PTGER4—skin cancer	0.000185	0.00096	CbGpPWpGaD
Oxymetazoline—HTR2B—Signaling Pathways—RASA1—skin cancer	0.000185	0.000959	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—MC1R—skin cancer	0.000183	0.000948	CbGpPWpGaD
Oxymetazoline—HTR1B—Signaling Pathways—PTGER4—skin cancer	0.000183	0.000948	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—GLI1—skin cancer	0.00018	0.000935	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—MC1R—skin cancer	0.000179	0.000929	CbGpPWpGaD
Oxymetazoline—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—skin cancer	0.000178	0.000922	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—GLI1—skin cancer	0.000176	0.000915	CbGpPWpGaD
Oxymetazoline—HTR2B—Signaling Pathways—PTCH1—skin cancer	0.000176	0.000914	CbGpPWpGaD
Oxymetazoline—HTR2B—Signaling Pathways—SMO—skin cancer	0.000176	0.000914	CbGpPWpGaD
Oxymetazoline—ADRA2C—Metabolism—ENO2—skin cancer	0.000175	0.000905	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—GLI2—skin cancer	0.000174	0.000904	CbGpPWpGaD
Oxymetazoline—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—skin cancer	0.000174	0.000903	CbGpPWpGaD
Oxymetazoline—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—skin cancer	0.000174	0.000902	CbGpPWpGaD
Oxymetazoline—ADRA1D—Signaling Pathways—SHH—skin cancer	0.000173	0.000898	CbGpPWpGaD
Oxymetazoline—ADRA1D—Signaling Pathways—RASA1—skin cancer	0.000172	0.000892	CbGpPWpGaD
Oxymetazoline—HTR2B—Signaling Pathways—PTGER4—skin cancer	0.000172	0.00089	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—SUFU—skin cancer	0.000171	0.000886	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—SUFU—skin cancer	0.000167	0.000868	CbGpPWpGaD
Oxymetazoline—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—skin cancer	0.000167	0.000864	CbGpPWpGaD
Oxymetazoline—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—skin cancer	0.000167	0.000864	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—MC1R—skin cancer	0.000166	0.000863	CbGpPWpGaD
Oxymetazoline—HTR1D—Signaling Pathways—FOXO4—skin cancer	0.000165	0.000855	CbGpPWpGaD
Oxymetazoline—ADRA1D—Signaling Pathways—SMO—skin cancer	0.000164	0.000851	CbGpPWpGaD
Oxymetazoline—ADRA1D—Signaling Pathways—PTCH1—skin cancer	0.000164	0.000851	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—GLI1—skin cancer	0.000164	0.00085	CbGpPWpGaD
Oxymetazoline—HTR1E—Signaling Pathways—TERT—skin cancer	0.000162	0.000842	CbGpPWpGaD
Oxymetazoline—HTR1B—Signaling Pathways—FOXO4—skin cancer	0.000161	0.000837	CbGpPWpGaD
Oxymetazoline—ADRA1D—Signaling Pathways—PTGER4—skin cancer	0.00016	0.000828	CbGpPWpGaD
Oxymetazoline—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—skin cancer	0.000159	0.000827	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling Pathways—SHH—skin cancer	0.000156	0.00081	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—SUFU—skin cancer	0.000155	0.000806	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling Pathways—RASA1—skin cancer	0.000155	0.000805	CbGpPWpGaD
Oxymetazoline—HTR2B—Signaling Pathways—FOXO4—skin cancer	0.000152	0.000786	CbGpPWpGaD
Oxymetazoline—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—skin cancer	0.000151	0.000784	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling Pathways—SHH—skin cancer	0.00015	0.000778	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling Pathways—RASA1—skin cancer	0.000149	0.000773	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling Pathways—PTCH1—skin cancer	0.000148	0.000768	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling Pathways—SMO—skin cancer	0.000148	0.000768	CbGpPWpGaD
Oxymetazoline—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—skin cancer	0.000148	0.000767	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling Pathways—SHH—skin cancer	0.000146	0.000757	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling Pathways—RASA1—skin cancer	0.000145	0.000752	CbGpPWpGaD
Oxymetazoline—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—skin cancer	0.000145	0.00075	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling Pathways—PTGER4—skin cancer	0.000144	0.000748	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—SHH—skin cancer	0.000144	0.000745	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—RASA1—skin cancer	0.000143	0.00074	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling Pathways—PTCH1—skin cancer	0.000142	0.000738	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling Pathways—SMO—skin cancer	0.000142	0.000738	CbGpPWpGaD
Oxymetazoline—ADRA2A—Metabolism—ENO2—skin cancer	0.000142	0.000735	CbGpPWpGaD
Oxymetazoline—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—skin cancer	0.000142	0.000734	CbGpPWpGaD
Oxymetazoline—ADRA1D—Signaling Pathways—FOXO4—skin cancer	0.000141	0.000732	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling Pathways—PTGER4—skin cancer	0.000138	0.000718	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling Pathways—PTCH1—skin cancer	0.000138	0.000718	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling Pathways—SMO—skin cancer	0.000138	0.000718	CbGpPWpGaD
Oxymetazoline—HTR1E—Signaling by GPCR—NRAS—skin cancer	0.000137	0.00071	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—PTCH1—skin cancer	0.000136	0.000706	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—SMO—skin cancer	0.000136	0.000706	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling Pathways—PTGER4—skin cancer	0.000135	0.000699	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—PTGER4—skin cancer	0.000133	0.000687	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—SHH—skin cancer	0.00013	0.000676	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—RASA1—skin cancer	0.000129	0.000672	CbGpPWpGaD
Oxymetazoline—HTR1E—Signaling Pathways—BRAF—skin cancer	0.000129	0.000667	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—SHH—skin cancer	0.000128	0.000662	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling Pathways—FOXO4—skin cancer	0.000127	0.000661	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—RASA1—skin cancer	0.000127	0.000658	CbGpPWpGaD
Oxymetazoline—ADRA2B—Hemostasis—NRAS—skin cancer	0.000125	0.000648	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—PTCH1—skin cancer	0.000124	0.000641	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—SMO—skin cancer	0.000124	0.000641	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling Pathways—FOXO4—skin cancer	0.000122	0.000634	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—PTCH1—skin cancer	0.000121	0.000627	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—SMO—skin cancer	0.000121	0.000627	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—PTGER4—skin cancer	0.00012	0.000624	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling Pathways—FOXO4—skin cancer	0.000119	0.000617	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—SHH—skin cancer	0.000119	0.000615	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—RASA1—skin cancer	0.000118	0.000611	CbGpPWpGaD
Oxymetazoline—HTR1E—Signaling by GPCR—KRAS—skin cancer	0.000118	0.000611	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—PTGER4—skin cancer	0.000118	0.000611	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—FOXO4—skin cancer	0.000117	0.000607	CbGpPWpGaD
Oxymetazoline—ADRA2C—Hemostasis—NRAS—skin cancer	0.000117	0.000605	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—SMO—skin cancer	0.000112	0.000583	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—PTCH1—skin cancer	0.000112	0.000583	CbGpPWpGaD
Oxymetazoline—HTR1D—Signaling Pathways—TERT—skin cancer	0.00011	0.000571	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—PTGER4—skin cancer	0.000109	0.000567	CbGpPWpGaD
Oxymetazoline—HTR1B—Signaling Pathways—TERT—skin cancer	0.000108	0.000559	CbGpPWpGaD
Oxymetazoline—ADRA2B—Hemostasis—KRAS—skin cancer	0.000108	0.000557	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—FOXO4—skin cancer	0.000106	0.000551	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—FOXO4—skin cancer	0.000104	0.000539	CbGpPWpGaD
Oxymetazoline—ADRA2C—Metabolism—ERCC2—skin cancer	0.000101	0.000526	CbGpPWpGaD
Oxymetazoline—HTR2B—Signaling Pathways—TERT—skin cancer	0.000101	0.000525	CbGpPWpGaD
Oxymetazoline—ADRA2C—Hemostasis—KRAS—skin cancer	0.0001	0.000521	CbGpPWpGaD
Oxymetazoline—HTR1E—Signaling by GPCR—HRAS—skin cancer	0.0001	0.000519	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—FOXO4—skin cancer	9.66e-05	0.000501	CbGpPWpGaD
Oxymetazoline—HTR1E—Signaling by GPCR—IL6—skin cancer	9.58e-05	0.000497	CbGpPWpGaD
Oxymetazoline—ADRA2B—Hemostasis—TP53—skin cancer	9.55e-05	0.000495	CbGpPWpGaD
Oxymetazoline—ADRA2A—Hemostasis—NRAS—skin cancer	9.48e-05	0.000491	CbGpPWpGaD
Oxymetazoline—ADRA1D—Signaling Pathways—TERT—skin cancer	9.42e-05	0.000489	CbGpPWpGaD
Oxymetazoline—HTR1D—Signaling by GPCR—NRAS—skin cancer	9.28e-05	0.000481	CbGpPWpGaD
Oxymetazoline—ADRA2B—Hemostasis—HRAS—skin cancer	9.14e-05	0.000474	CbGpPWpGaD
Oxymetazoline—HTR1B—Signaling by GPCR—NRAS—skin cancer	9.08e-05	0.000471	CbGpPWpGaD
Oxymetazoline—ADRA2C—Hemostasis—TP53—skin cancer	8.93e-05	0.000463	CbGpPWpGaD
Oxymetazoline—HTR1D—Signaling Pathways—BRAF—skin cancer	8.72e-05	0.000452	CbGpPWpGaD
Oxymetazoline—HTR1B—Signaling Pathways—BRAF—skin cancer	8.54e-05	0.000443	CbGpPWpGaD
Oxymetazoline—ADRA2C—Hemostasis—HRAS—skin cancer	8.54e-05	0.000443	CbGpPWpGaD
Oxymetazoline—HTR2B—Signaling by GPCR—NRAS—skin cancer	8.53e-05	0.000442	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling Pathways—TERT—skin cancer	8.51e-05	0.000441	CbGpPWpGaD
Oxymetazoline—ADRA2A—Metabolism—ERCC2—skin cancer	8.24e-05	0.000427	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling Pathways—TERT—skin cancer	8.17e-05	0.000424	CbGpPWpGaD
Oxymetazoline—ADRA2A—Hemostasis—KRAS—skin cancer	8.16e-05	0.000423	CbGpPWpGaD
Oxymetazoline—HTR1E—Signaling Pathways—NRAS—skin cancer	8.08e-05	0.000419	CbGpPWpGaD
Oxymetazoline—HTR2B—Signaling Pathways—BRAF—skin cancer	8.02e-05	0.000416	CbGpPWpGaD
Oxymetazoline—HTR1D—Signaling by GPCR—KRAS—skin cancer	7.98e-05	0.000414	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling Pathways—TERT—skin cancer	7.95e-05	0.000412	CbGpPWpGaD
Oxymetazoline—ADRA1D—Signaling by GPCR—NRAS—skin cancer	7.94e-05	0.000412	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—TERT—skin cancer	7.82e-05	0.000406	CbGpPWpGaD
Oxymetazoline—HTR1B—Signaling by GPCR—KRAS—skin cancer	7.82e-05	0.000405	CbGpPWpGaD
Oxymetazoline—ADRA1D—Signaling Pathways—BRAF—skin cancer	7.46e-05	0.000387	CbGpPWpGaD
Oxymetazoline—HTR2B—Signaling by GPCR—KRAS—skin cancer	7.34e-05	0.000381	CbGpPWpGaD
Oxymetazoline—ADRA2A—Hemostasis—TP53—skin cancer	7.25e-05	0.000376	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling by GPCR—NRAS—skin cancer	7.17e-05	0.000372	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—TERT—skin cancer	7.1e-05	0.000368	CbGpPWpGaD
Oxymetazoline—HTR1E—Signaling Pathways—KRAS—skin cancer	6.96e-05	0.000361	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—TERT—skin cancer	6.95e-05	0.00036	CbGpPWpGaD
Oxymetazoline—ADRA2A—Hemostasis—HRAS—skin cancer	6.93e-05	0.00036	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling by GPCR—NRAS—skin cancer	6.88e-05	0.000357	CbGpPWpGaD
Oxymetazoline—ADRA1D—Signaling by GPCR—KRAS—skin cancer	6.83e-05	0.000354	CbGpPWpGaD
Oxymetazoline—HTR1D—Signaling by GPCR—HRAS—skin cancer	6.79e-05	0.000352	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling Pathways—BRAF—skin cancer	6.74e-05	0.000349	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling by GPCR—NRAS—skin cancer	6.7e-05	0.000347	CbGpPWpGaD
Oxymetazoline—HTR1B—Signaling by GPCR—HRAS—skin cancer	6.65e-05	0.000345	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling by GPCR—NRAS—skin cancer	6.59e-05	0.000342	CbGpPWpGaD
Oxymetazoline—HTR1D—Signaling by GPCR—IL6—skin cancer	6.5e-05	0.000337	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling Pathways—BRAF—skin cancer	6.47e-05	0.000336	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—TERT—skin cancer	6.46e-05	0.000335	CbGpPWpGaD
Oxymetazoline—HTR1B—Signaling by GPCR—IL6—skin cancer	6.36e-05	0.00033	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling Pathways—BRAF—skin cancer	6.29e-05	0.000326	CbGpPWpGaD
Oxymetazoline—HTR2B—Signaling by GPCR—HRAS—skin cancer	6.24e-05	0.000324	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—BRAF—skin cancer	6.19e-05	0.000321	CbGpPWpGaD
Oxymetazoline—HTR1E—Signaling Pathways—TP53—skin cancer	6.18e-05	0.000321	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling by GPCR—KRAS—skin cancer	6.17e-05	0.00032	CbGpPWpGaD
Oxymetazoline—ADRA2C—Metabolism—PTGS2—skin cancer	6.08e-05	0.000315	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling by GPCR—NRAS—skin cancer	5.98e-05	0.00031	CbGpPWpGaD
Oxymetazoline—HTR2B—Signaling by GPCR—IL6—skin cancer	5.97e-05	0.00031	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling by GPCR—KRAS—skin cancer	5.93e-05	0.000307	CbGpPWpGaD
Oxymetazoline—HTR1E—Signaling Pathways—HRAS—skin cancer	5.91e-05	0.000307	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling by GPCR—NRAS—skin cancer	5.85e-05	0.000304	CbGpPWpGaD
Oxymetazoline—ADRA1D—Signaling by GPCR—HRAS—skin cancer	5.81e-05	0.000301	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling by GPCR—KRAS—skin cancer	5.76e-05	0.000299	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling by GPCR—KRAS—skin cancer	5.67e-05	0.000294	CbGpPWpGaD
Oxymetazoline—HTR1E—Signaling Pathways—IL6—skin cancer	5.66e-05	0.000294	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—BRAF—skin cancer	5.62e-05	0.000291	CbGpPWpGaD
Oxymetazoline—ADRA1D—Signaling by GPCR—IL6—skin cancer	5.56e-05	0.000288	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—BRAF—skin cancer	5.5e-05	0.000285	CbGpPWpGaD
Oxymetazoline—HTR1D—Signaling Pathways—NRAS—skin cancer	5.48e-05	0.000284	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling by GPCR—NRAS—skin cancer	5.44e-05	0.000282	CbGpPWpGaD
Oxymetazoline—HTR1B—Signaling Pathways—NRAS—skin cancer	5.37e-05	0.000278	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling by GPCR—HRAS—skin cancer	5.24e-05	0.000272	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling by GPCR—KRAS—skin cancer	5.15e-05	0.000267	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—BRAF—skin cancer	5.11e-05	0.000265	CbGpPWpGaD
Oxymetazoline—HTR2B—Signaling Pathways—NRAS—skin cancer	5.04e-05	0.000261	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling by GPCR—KRAS—skin cancer	5.04e-05	0.000261	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling by GPCR—HRAS—skin cancer	5.04e-05	0.000261	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling by GPCR—IL6—skin cancer	5.02e-05	0.00026	CbGpPWpGaD
Oxymetazoline—ADRA2A—Metabolism—PTGS2—skin cancer	4.94e-05	0.000256	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling by GPCR—HRAS—skin cancer	4.9e-05	0.000254	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling by GPCR—HRAS—skin cancer	4.82e-05	0.00025	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling by GPCR—IL6—skin cancer	4.82e-05	0.00025	CbGpPWpGaD
Oxymetazoline—HTR1D—Signaling Pathways—KRAS—skin cancer	4.72e-05	0.000245	CbGpPWpGaD
Oxymetazoline—ADRA1D—Signaling Pathways—NRAS—skin cancer	4.69e-05	0.000243	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling by GPCR—IL6—skin cancer	4.69e-05	0.000243	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling by GPCR—KRAS—skin cancer	4.68e-05	0.000243	CbGpPWpGaD
Oxymetazoline—HTR1B—Signaling Pathways—KRAS—skin cancer	4.62e-05	0.000239	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling by GPCR—IL6—skin cancer	4.61e-05	0.000239	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling by GPCR—HRAS—skin cancer	4.37e-05	0.000227	CbGpPWpGaD
Oxymetazoline—HTR2B—Signaling Pathways—KRAS—skin cancer	4.34e-05	0.000225	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling by GPCR—HRAS—skin cancer	4.28e-05	0.000222	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling Pathways—NRAS—skin cancer	4.23e-05	0.00022	CbGpPWpGaD
Oxymetazoline—HTR1D—Signaling Pathways—TP53—skin cancer	4.19e-05	0.000217	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling by GPCR—IL6—skin cancer	4.19e-05	0.000217	CbGpPWpGaD
Oxymetazoline—HTR1B—Signaling Pathways—TP53—skin cancer	4.1e-05	0.000213	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling by GPCR—IL6—skin cancer	4.1e-05	0.000213	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling Pathways—NRAS—skin cancer	4.07e-05	0.000211	CbGpPWpGaD
Oxymetazoline—ADRA1D—Signaling Pathways—KRAS—skin cancer	4.04e-05	0.000209	CbGpPWpGaD
Oxymetazoline—HTR1D—Signaling Pathways—HRAS—skin cancer	4.01e-05	0.000208	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling by GPCR—HRAS—skin cancer	3.98e-05	0.000206	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling Pathways—NRAS—skin cancer	3.96e-05	0.000205	CbGpPWpGaD
Oxymetazoline—HTR1B—Signaling Pathways—HRAS—skin cancer	3.93e-05	0.000204	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—NRAS—skin cancer	3.89e-05	0.000202	CbGpPWpGaD
Oxymetazoline—HTR2B—Signaling Pathways—TP53—skin cancer	3.86e-05	0.0002	CbGpPWpGaD
Oxymetazoline—HTR1D—Signaling Pathways—IL6—skin cancer	3.84e-05	0.000199	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling by GPCR—IL6—skin cancer	3.81e-05	0.000197	CbGpPWpGaD
Oxymetazoline—HTR1B—Signaling Pathways—IL6—skin cancer	3.76e-05	0.000195	CbGpPWpGaD
Oxymetazoline—HTR2B—Signaling Pathways—HRAS—skin cancer	3.69e-05	0.000191	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling Pathways—KRAS—skin cancer	3.64e-05	0.000189	CbGpPWpGaD
Oxymetazoline—ADRA1D—Signaling Pathways—TP53—skin cancer	3.59e-05	0.000186	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—NRAS—skin cancer	3.53e-05	0.000183	CbGpPWpGaD
Oxymetazoline—HTR2B—Signaling Pathways—IL6—skin cancer	3.53e-05	0.000183	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling Pathways—KRAS—skin cancer	3.5e-05	0.000181	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—NRAS—skin cancer	3.46e-05	0.000179	CbGpPWpGaD
Oxymetazoline—ADRA1D—Signaling Pathways—HRAS—skin cancer	3.43e-05	0.000178	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling Pathways—KRAS—skin cancer	3.4e-05	0.000177	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—KRAS—skin cancer	3.35e-05	0.000174	CbGpPWpGaD
Oxymetazoline—ADRA1D—Signaling Pathways—IL6—skin cancer	3.28e-05	0.00017	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling Pathways—TP53—skin cancer	3.24e-05	0.000168	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—NRAS—skin cancer	3.21e-05	0.000167	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling Pathways—TP53—skin cancer	3.11e-05	0.000161	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling Pathways—HRAS—skin cancer	3.1e-05	0.000161	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—KRAS—skin cancer	3.04e-05	0.000158	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling Pathways—TP53—skin cancer	3.03e-05	0.000157	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—TP53—skin cancer	2.98e-05	0.000154	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—KRAS—skin cancer	2.98e-05	0.000154	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling Pathways—HRAS—skin cancer	2.98e-05	0.000154	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling Pathways—IL6—skin cancer	2.97e-05	0.000154	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling Pathways—HRAS—skin cancer	2.89e-05	0.00015	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—HRAS—skin cancer	2.85e-05	0.000148	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling Pathways—IL6—skin cancer	2.85e-05	0.000148	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling Pathways—IL6—skin cancer	2.77e-05	0.000144	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—KRAS—skin cancer	2.77e-05	0.000143	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—IL6—skin cancer	2.73e-05	0.000141	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—TP53—skin cancer	2.7e-05	0.00014	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—TP53—skin cancer	2.65e-05	0.000137	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—HRAS—skin cancer	2.58e-05	0.000134	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—HRAS—skin cancer	2.53e-05	0.000131	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—IL6—skin cancer	2.47e-05	0.000128	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—TP53—skin cancer	2.46e-05	0.000127	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—IL6—skin cancer	2.42e-05	0.000126	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—HRAS—skin cancer	2.35e-05	0.000122	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—IL6—skin cancer	2.25e-05	0.000117	CbGpPWpGaD
